Belantamab (TNFRSF17/CD269) - Research Grade Biosimilar
Product Specifications
Background
Belantamab mafodotin (GSK2857916) is antibody-conjugated drug that connects humanized anti-BCMA antibodies with cytotoxic agents, and specifically targets BCMA to deliver cytotoxic agents into MM cells to kill cancer cells effect.
Immunogen
Humanized / TNFRSF17/CD269 [Homo sapiens]
Clonality
Recombinant Monoclonal
Conjugation
Unconjugated
Type
Primary Antibodies, Biosimilars
Source
CHO cells
Field of Research
Cancer
Purification
>95%
Concentration
Batch dependent
Buffer
PBS buffer pH7.5
Modification
None
Shipping Conditions
Blue Ice
Storage Conditions
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 ˚ C for 1-2 weeks. Store at -20 ˚ C for 12 months. Store at -80 ˚ C for long term storage.
Fragment
IgG1-kappa
NCBI Organism
Homo sapiens
Other Product Names
2857916, GSK2857916, J6M0, J6M0-mcMMAF
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC682808-100 1x 100 µL
Cytokeratin 18 (KRT18) (KRT18/2808R), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 